G2GBIO (456160.KQ) — Stock Score Summary

G2GBIO (456160.KQ) has a MoatMap StockRank of 5/100 based on Quality (36/100), Value (20/100), and Momentum (25/100) factor scores. The current signal is STRONG SELL.

G2GBIO Inc., a clinical-stage biotech company, provides pharmaceutical products. The company's pipeline products include GB-5001, GB-5001A, and GB-5112 for the treatment of Alzheimer's disease; GB-6002, an opioid drug that is used for post-operative pain treatment; GB-7001 for type-2 diabetes...

Key Financial Metrics

Price$29.92
Market Cap$514M
Price/Book12.67
Return on Equity-20.7%
Return on Invested Capital-18.8%
Debt/Equity12.22
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-6K

G2GBIO operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is G2GBIO’s (456160.KQ) StockRank?
MoatMap’s StockRank for G2GBIO (456160.KQ) is 5/100, with a Strong Sell signal. It is a composite of Quality (36), Value (20), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does G2GBIO have an economic moat?
G2GBIO (456160.KQ) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is G2GBIO a buy, hold, or sell?
MoatMap’s current signal for G2GBIO (456160.KQ) is Strong Sell, based on a StockRank of 5/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is G2GBIO in?
G2GBIO (456160.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks456160.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock